Ashland
About: Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.
Employees: 2,960
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
32% more repeat investments, than reductions
Existing positions increased: 139 | Existing positions reduced: 105
5.31% more ownership
Funds ownership: 91.04% [Q1] → 96.34% (+5.31%) [Q2]
7% less funds holding
Funds holding: 366 [Q1] → 342 (-24) [Q2]
13% less capital invested
Capital invested by funds: $2.54B [Q1] → $2.22B (-$325M) [Q2]
22% less call options, than puts
Call options by funds: $6.4M | Put options by funds: $8.2M
28% less first-time investments, than exits
New positions opened: 52 | Existing positions closed: 72
50% less funds holding in top 10
Funds holding in top 10: 2 [Q1] → 1 (-1) [Q2]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Morgan Stanley
|
$60
|
Equal-Weight
Initiated
|
8 Sep 2025 |
BMO Capital
John McNulty
|
$61
|
Market Perform
Maintained
|
2 Sep 2025 |
Argus Research
Alexandra Yates
|
$65
|
Buy
Maintained
|
26 Aug 2025 |
UBS
Joshua Spector
|
$64
|
Buy
Maintained
|
7 Aug 2025 |
Wells Fargo
Michael Sison
|
$53
|
Equal-Weight
Maintained
|
31 Jul 2025 |
Financial journalist opinion